Emergent BioSolutions Inc. — Director's Dealing 2012

Dec 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2012-12-12

Reporting Person: El-Hibri Fuad (Director, Chairman, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-12	Common Stock	G	304098	—	Acquired	304098	Indirect
2012-12-14	Common Stock	G	224628	—	Acquired	224628	Indirect
2012-12-14	Common Stock	G	176378	—	Disposed	127721	Indirect
2012-12-14	Common Stock	G	13333	—	Acquired	13333	Indirect
2012-12-14	Common Stock	G	13333	—	Acquired	13333	Indirect
2012-12-14	Common Stock	G	149712	—	Acquired	149712	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1638403	Indirect
Common Stock	1845570	Direct
Common Stock	15845	Indirect
Common Stock	15845	Indirect
Common Stock	15845	Indirect
Common Stock	1524155	Indirect
Common Stock	865043	Indirect

Footnotes

F1: This transaction involved a gift of securities by the reporting person to his wife, who shares the reporting person's household. These shares were previously reported as indirectly owned by the reporting person through his interest in Intervac, L.L.C.

F2: The reporting disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.

F3: This transaction involved a gift of securities by the reporting person to a trust held for the benefit of the reporting person's family. These shares were previously reported as indirectly owned by the reporting person through his interest in Intervac, L.L.C. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and this report should not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F4: Represents gifts from the reporting person's wife to the Roula El-Hibri Trust, the Sami El-Hibri Trust and the El-Hibri Descendants Trust.

F5: These shares are held in a trust for the benefit of the reporting person's descendants. The reporting person is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F6: These shares are held in a trust for the benefit of the reporting person's children. The reporting person's wife is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F7: Mr. El-Hibri holds these shares with his wife, as tenants by the entirety.

F8: Mr. El-Hibri's direct holdings include restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.

F9: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F10: Mr. El-Hibri holds individually and with his wife, as tenants by the entirety, an aggregate 89.2% equity interest in Biovac, L.L.C. Biovac, L.L.C. is the direct owner of 1,524,155 shares of Common Stock. Mr. El-Hibri disclaims beneficial ownership of the shares of Common Stock directly owned by Biovac, L.L.C. for purposes of Section 16, except to the extent of his pecuniary interest in 1,359,546 shares.

F11: Mr. El-Hibri is the holder of a 40.17% (567,582.3 units) equity interest in BioPharm, L.L.C. BioPharm, L.L.C. is the direct owner of 865,043 shares of Common Stock. Mr. El-Hibri disclaims beneficial ownership of these shares for purposes of Section 16, except to the extent of his pecuniary interest in 347,488 shares.